To the treatment of diabetes mellitus with insulin

2021 ◽  
Vol 20 (1) ◽  
pp. 96-97
Author(s):  
R. Luria

Among the numerous studies on the effect of insulin, discovered by Banting, a hormone that regulates carbohydrate metabolism, of course, observations deserve special attention. Noogdenʹa, one of the creators of the modern theory of diabetes. No Orden and Isaac (Klin. Woch., 1923, No. 43) summarize their observations of 50 insulin-treated diabetics. The authors emphasize from the outset that the superiority of insulin treatment over other methods of diabetes treatment is beyond question, both in terms of the effect on glycosuria and in relation to acidosis.

Author(s):  
Dimple . ◽  
Ashwani Kumar ◽  
Vikas Kumar ◽  
Vidisha Tomer

Diabetes mellitus (DM) is a chronic disease which has clinched the world. More than 300 million people of the world are suffering from this disease and the number is still increasing at a rapid rate as modern medical science has no permanent solution for the disease. Current scenario of the nutraceuticals has increased patient’s faith on the traditional medicinal system and world nutraceutical industry is estimated to reach $285.0 billion by 2021. The increasing trend of nutraceuticals in diabetes treatment makes it important to collect the traditional knowledge of medicines under one heading as it can help researchers to formulate new functional foods and nutraceuticals which can either lower down the risk or cure DM. In addition, the discussion of market available food products, their active components and possible health benefits can help the patients to understand the herbal medicines in a better way.


Diabetes ◽  
1974 ◽  
Vol 23 (3) ◽  
pp. 240-246 ◽  
Author(s):  
C. D. Saudek ◽  
P. R. Boulter ◽  
R. H. Knopp ◽  
R. A. Arky

1971 ◽  
Vol 55 (4) ◽  
pp. 861-876 ◽  
Author(s):  
Rubin Bressler ◽  
John A. Galloway

Author(s):  
Lesley K Bowker ◽  
James D Price ◽  
Sarah C Smith

The ageing endocrine system 420 Diabetes mellitus 422 HOW TO . . . Diagnose diabetes in older people 423 Diabetes: treatment 424 Diabetes: oral drug treatment 426 HOW TO . . . Manage older diabetic people in care homes 427 Diabetes: insulin treatment 428 Diabetes: complications 430 Diabetic emergencies 432 HOW TO . . . Manage diabetes in the terminally ill patient ...


2020 ◽  
Vol 26 ◽  
Author(s):  
Lavanya Rayapu ◽  
Kajal Chakraborty ◽  
Lokanatha Valluru

Background: Diabetes Mellitus (DM) is a major chronic metabolic disorder, characterize by hyperglycemia that leads to several complications such as retinopathy, atherosclerosis, nephropathy etc. In 2019, it was estimated that about 463 million people were suffering with diabetes and it may increase up to 700 million in 2045. Marine macroalgae are the rich source of bioactive compounds for the treatment of diabetes mellitus. Objective: This review summarizes the recent epidemiology and possible use of marine macroalgae-derived bioactive compounds for the protection against chronic metabolic disease, diabetes mellitus and marine macroalgae as a nutraceutical supplements. Conclusion: The present therapies available for the diabetes treatment are oral medicines and insulin injections. But continuous use of synthetic medicines provides low therapeutic with many side effects. In continuing search of antidiabetic drugs, marine macroalgae remain as a promising source with potent bioactivity. Among existing marine algae, red and brown algae are reported to show anti-diabetic activity. Hence, the present review focuses on the epidemiology, diabetes biomarkers and different secondary bioactive compounds present in marine macroalgae to treat the diabetes mellitus.


Sign in / Sign up

Export Citation Format

Share Document